Not Signed In -
Baclofen Disintegrating Tablets |
Lioresal Disintegrating Tablet |
Clinical Trial: Baclofen for the Treatment of Cocaine Dependence - 1
This study is currently recruiting patients.
Purpose
The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Baclofen | Phase II |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Placebo Control, Parallel Assignment
Official Title: Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence
Further Study Details:
Expected Total Enrollment: 160
Study start: June 2004; Expected completion: November 2005
Double-blind, placebo-controlled, parallel design trial of baclofen for the treatment of cocaine dependence
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Subject must have DSM-IV diagnosis of cocaine dependence.
- Subject must be seeking treatment for cocaine dependence.
- Be be able to verbalize understanding of consent form, provide written consent and verbalize willingness to complete study procedures.
Exclusion Criteria:
- Please contact site for more information.
Location and Contact Information
California
San Francisco General Hosptial, San Francisco, California, 94110, United States; Recruiting
Omar Ahsanuddin 415-502-9602
Torrance Site, Torrance, California, 90502, United States; Recruiting
Jason Mcculler, M.A. 310-224-4670
Colorado
Denver VA Medical Center, Denver, Colorado, 80220, United States; Recruiting
Lori Clapp 303-399-8020 Ext. 3374
Maryland
VA Maryland Healthcare System, Baltimore, Maryland, 21201, United States; Recruiting
Mark Mann, M.A. 410-605-7000 Ext. 4864
Pennsylvania
U of Penn School of Medicine, Philadelphia, Pennsylvania, 19104 6178, United States; Recruiting
Anna Fornash 215-222-3200 Ext. 165
Texas
South TX VA Health Care System, San Antonio, Texas, 78284 4404, United States; Recruiting
Rochelle Javors 210-617-5300 Ext. 5949
Utah
Salt Lake City VA Medical Center, Salt Lake City, Utah, 84148, United States; Recruiting
Suzanne Plumb 801-582-1565 Ext. 4220
Virginia
Institute of Resch & Educ Inova Fairfax Hospital, Falls Church, Virginia, 22042 3300, United States; Recruiting
Laurie Holland, R.N. 703-205-2491
Study chairs or principal investigators
Liza Gorgon, M.A., Principal Investigator, VA Maryland Health Care System
More Information
Study ID Numbers: NIDA-CSP-1021-1
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: May 11, 2004
ClinicalTrials.gov Identifier: NCT00082485
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: May 11, 2004
ClinicalTrials.gov Identifier: NCT00082485
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Baclofen Disintegrating Tablets (Drug Digest)
- Lioresal Disintegrating Tablet (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
